Final Call: $1M Investment Opportunity for Deep-Tech Startups as Luminate NY Application Window Closes Jan. 12 World's Largest Accelerator for Optics, Photonics, and Imaging (OPI) Offers $100K Immediate Funding and Strategic Access to the “Optics Capital of the World” GlobeNewswire January 08, 2026 ROCHESTER, N.Y., Jan. 08, 2026 (GLOBE NEWSWIRE) — Early-stage technology companies have […]

Alliance Entertainment Appoints Jeffrey Smith as Senior Vice President of Sales and Marketing for Alliance Authentic(TM) GlobeNewswire January 08, 2026 PLANTATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (NASDAQ: AENT), the world's largest distributor of vinyl records and a leading curator of physical entertainment products and collectibles, today announced the appointment

RenovoRx To Announce Promising New Clinical Data Using its TAMP(TM) Therapy Platform in an Abstract to be Presented at ASCO GI 2026 GlobeNewswire January 08, 2026 New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx's TAMP Therapy Platform as a Targeted Drug-Delivery Approach Data Shows a PK

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004 GlobeNewswire January 08, 2026 – First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician's choice of chemotherapy in HER2-positive metastatic breast cancer; interim analysis anticipated Q3 2026 – – Third dose cohort

TON Strategy Company Announces Senior Officer Appointments GlobeNewswire January 08, 2026 LAS VEGAS, Jan. 08, 2026 (GLOBE NEWSWIRE) — TON Strategy Company (Nasdaq: TONX), a digital asset treasury company dedicated to holding Toncoin ($TON), today announced the appointments of Mary L. Marbach as General Counsel and Corporate Secretary and Bill J. Rivard as Chief Accounting

Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook GlobeNewswire January 08, 2026 Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 IBSRELA achieved $274 million in revenue in 2025, representing 73% growth vs. 20241 IBSRELA expected to achieve $410-430 million in revenue in 2026 IBSRELA revenue expected to

Behavioral Labs Inc. (BLINC) and Samsung Partner to Deliver Dynamic Software Solutions GlobeNewswire January 08, 2026 CANTON, Ohio, Jan. 08, 2026 (GLOBE NEWSWIRE) — Behavioral Labs Inc. (BLINC) today announced a new partnership with Samsung Electronics America, Inc. to develop dynamic software solutions that strengthen Samsung Visual eXperience Transformation (VXT), the company's cutting-edge content management

Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T GlobeNewswire January 08, 2026 1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line (1L) Consolidation

Leslie's, Inc. Appoints John Hartmann to Board of Directors GlobeNewswire January 08, 2026 PHOENIX, Jan. 08, 2026 (GLOBE NEWSWIRE) — Leslie's, Inc. (“Leslie's” or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, announced that it has appointed

PharmAla To Supply Østfold Hospital Trust with LaNeo(TM) MDMA for Clinical Research GlobeNewswire January 08, 2026 TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo(TM) MDMA and novel derivatives of MDMA (MDXX class molecules),